LP01™ + LA02 (PROBIAL FLAT BELLY)

Blend
Blend
On this page

Gastroenterology

Antipathogenic activity

Functionality

Anti-inflammatory activity

Eases gastrointestinal discomfort

Inhibits pathogenic E. coli and other pathogens

Available Formats

Single strain

Blend

Finished dosage form

Scientific Support
Clinical studies

In vitro studies

a) Mogna L. et al. Assessment of the In Vitro Inhibitory Activity of Specific Probiotic Bacteria Against Different Escherichia coli strains. J. Clin. Gastroenterol. 2012;46 Suppl.S29-32.  Doi: 10.1097/MCG.0b013e31826852b7

b) Nicola S. et al. Interaction between probiotics and human immune cells: the prospective anti-inflammatory activity of Bifidobacterium breve BR03. AgroFOOD, 2010; 21(2):S44-47.

c) Amoruso A. et al. A Systematic Evaluation of the Immunomodulatory and Functional Properties of Probiotic Bifidobacterium Breve BR03 (DSM 16604) Lactobacillus plantarum LP01 (LMG P-21021). J Prob Health. 2019;  7:214. Doi: 10.35248/2329-8901.19.7.214

d) Deidda F, et al. How Probiotics may Kill Harmful Bacteria: The in vitro Activity against Some Haemolytic Strains. J Prob Health, 2020. Vol. 8 Iss.2 No: 216.  DOI: 10.35248/2329-8901.20.8.216                                              

Internal in vitro data on gut permeability available upon request

Associations